ArticleCureus2025
Oligometastatic Breast Cancer With Cutaneous Involvement and Paraneoplastic Hypercalcemia in a Young Woman.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous involvement in breast cancer is typically associated with locally advanced or neglected disease. In young women, such presentations are often associated with a more aggressive biological behavior. We report the case of a woman in her early 40s presenting with a large, cutaneous-involved, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, right breast cancer with neuroendocrine differentiation. Imaging revealed axillary, supraclavicular, and right cervical lymph node involvement, with no evidence of distant metastasis. Laboratory evaluation at diagnosis demonstrated malignant hypercalcemia refractory to medical treatment. The patient received neoadjuvant chemotherapy, achieving resolution of hypercalcemia and a significant clinical and radiologic response, followed by surgery, radiotherapy, and adjuvant endocrine therapy. At 24 months post-surgery, the patient remains free of disease. This case underscores the importance of prompt multidisciplinary management in aggressive presentations of breast cancer, even when associated with paraneoplastic syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.